Home Theralase Technologies

Theralase Technologies

In operation
Post-IPO Round
Biopharmaceutical Manufacturer
Basic
Enterprise Profile

Basic Information

Theralase Technologies is a biopharmaceutical company focused on the design, development, manufacturing, and sale of patented laser technology platforms for various biostimulation and biodisruptive clinical applications in patients. Committed to the research and development of photoactivated photodynamic compounds and their associated drug formulations, aiming to safely and effectively eradicate various cancers. We are dedicated to the R&D of preventing, alleviating, and treating diseases, continuously improving the quality of life for cancer patients. Serving our higher purpose by bringing hope to cancer treatment.
Theralase Technologies Inc.
Toronto,Ontario,Canada
15~50 people
January 01, 1994
info@theralase.com

Enterprise Profile

Industrial Sector
Compound Discovery New Drug Development Medical Device R&D and Design Biological Drug Production Biological Product Manufacturing Therapeutic Manufacturing
Concept
Tumor
Application Scenarios
Biologics Innovative Drugs Medical Devices Medical Equipment